Johnson & Johnson reported sales at its Jacksonville-based vision care products business fell in the first quarter, but it expects a rebound for the rest of 2024.
Total vision sales fell 3.3% to $1.258 billion, with sales of contact lenses dropping 4.6% to $910 million.
Sales of surgical products for vision rose slightly.